Reliability of clinical research on invasive fungal infections: A systematic review of the literature

Medical Mycology

Volumn 39, Issue 1, 2001, Pages 35-40

  Ascioglu, S ^a,c   De Pauw, B E ^a   Donnelly, J P ^b   Collette, L ^a  

^a EORTC DATA CENTER   (Belgium)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Immunocompromised patient; Invasive fungal infections; Reliability; Systematic review

Indexed keywords

ASPERGILLOSIS; ASPERGILLUS; CANDIDA; CASE CONTROL STUDY; CLINICAL RESEARCH; CLINICAL TRIAL; COHORT ANALYSIS; DATA BASE; DIAGNOSTIC VALUE; FUNGUS; HUMAN; IMMUNE DEFICIENCY; MEDICAL INFORMATION; METHODOLOGY; MOULD; MYCOSIS; NOMENCLATURE; NONHUMAN; RELIABILITY; REVIEW; STATISTICAL ANALYSIS; YEAST;

ASPERGILLUS; CANDIDA; FUNGI;

EID: 0035125677     PISSN: 13693786     EISSN: None     Source Type: Journal    
DOI: 10.1080/mmy.39.1.35.40     Document Type: Review

References (22)

1. Keye JD. Magee WE. Fungal diseases in a genera] hospital: study of 88 cases. Am J Clin Palhol 1956; 26: 1235-1253.
2. Armstrong D. Overview of invasive fungal infections and clinical presentation. Bailliere's Clin Infect Dis 1995; 2: 17-24.
3. Gøtzsche PC, Johansen KH. Meta-analysis of prophylactic or empirical antifungal treatment versus placebo or no treatment in patients with cancer complicated by neutropenia. BMJ 1997; 314: 1238-1244.
4. Kelsey .IL, Whittemore AS. Evans AS. Thompson WD (eds). Measurement error. In: Methods in Observational Epidemiology, 2nd edn. New York: Oxford University Press. 1996: 345-363.
5. Koran ML. Reliability of clinical methods, data, and judgments. New Engl J Med 1975; 293: 642-646.
6. Feinstein AR. An additional basic science for clinical medicine: III. The challenges of comparison and measurement. Ann Intern Med 1983; 99: 705-712.
7. Feinstein AR. An additional basic science for clinical medicine: IV. The developments of clinimetrics. Ann Intern Med 1983: 99: 843-848.
8. Fleiss JL (ed). Statistical Methods for Rates and Proportions. 2nd edn. New York: John Wiley, 1981.
9. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977: 33: 159-174.
10. Grant JM. The fetal heart rate trace is normal, isn't it? Observer agreement for categorical assessments. Lancet 1991; 337: 215-218.
11. Landis JR, Koch GG. An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics 1977; 33: 363-374.
12. Chopra R, Blair S, Strang J, Cervi P, Patterson KG, Goldstone AH. Liposomal amphotericin B (AmBisome) in the treatment of fungal infections in neutropenic patients. J Antimicrob Chemother 1991: 28: 93-104.
13. Nucci M, Pulcheri W, Bâcha PC, et al. Amphotericin B followed by itraconazole in the treatment of disseminated fungal infections in neutropenic patients. Mycoses 1994; 37: 433-437.
14. Mills W. Chopra R, Linch DC, Goldstone AH. Liposomal amphotericin B in the treatment of fungal infections in neutropenic patients: a single-center experience of 133 episodes in 116 patients. Br J Haemaloi 1994; 86: 754-760.
15. Berenguer J, Munoz P. Parras F. Fernandez-Baca V. Hernandez-Sampelayo T. Bouza E. Treatment of deep mycoses with liposomal amphotericin B. EurJ Clin Microbiol Infect Dis 1994: 13: 504-507.
16. Nemunaitis J, Meyers JD, Buckner CD. Phase I trial of recombinant human colony stimulating factor in patients with invasive fungal infections. Blood 1991; 78: 907-903.
17. Anaissie EJ. Darouiche RO, Ahi-Said D. Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature, din Infect Dis 1996: 23:964-972.
18. Anaissie EJ, Kontoyiannis DP, Vartivarian S. Effectiveness of an oral triazole for opportunistic mold infections in patients with cancer: experience with SCH 39304. Clin Infect Dis 1993; 17: 1022-1031.
19. Verweij PE. Donnelly JP, Kullberg BJ, Meis JFGM, de Pauw BE. Amphotericin B versus amphotericin B plus 5-flucytosine: poor results in the treatment of proven systemic mycoses in neutropenic patients. Infection 1994: 22: 81-85.
20. Denning DW, Lee JY, Hosteller JS, et al. NIAID mycoses study group multicenter trial of oral itraconazole therapy for invasive aspergillosis. Am J Med 1994; 97: 135-144.
21. Sackett DL, Haynes BR, Guyatt GH. Tugwell P (eds). Tracking down the evidence to solve clinical problems. In: Clinical Epidemiology. A Basic Science for Clinical Medicine. 2nd edn. Boston: Little, Brown and Company, 1991: 335-358.
22. Fleiss JL (ed). Design and Analysis of Clinical Experiments. New York: John Wiley & Sons. 1986.